Alleviates hyperlipidemia, fat accumulation, and the formation of atherosclerosis in ApoE−/− mice, reverses the expression of PCSK9 mRNA in liver tissues and circulating PCSK9 levels in ApoE−/− mice, and upregulates the expression of liver LDLR. Here, PCSK9 is linked to hyperlipidemia.